Cell Membrane Integrity in Myotonic Dystrophy Type 1: Implications for Therapy-Reference-Cited by-同舟云学术

Cell Membrane Integrity in Myotonic Dystrophy Type 1: Implications for Therapy

Published:2015-03-23 Issue:3 Volume:10 Page:e0121556
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

González-Barriga Anchel,Kranzen Julia,Croes Huib J. E.,Bijl Suzanne,van den Broek Walther J. A. A.,van Kessel Ingeborg D. G.,van Engelen Baziel G. M.,van Deutekom Judith C. T.,Wieringa Bé,Mulders Susan A. M.,Wansink Derick G.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference47 articles.

1. Expanding complexity in myotonic dystrophy;P Groenen;BioEssays,1998

2. The myotonic dystrophies: molecular, clinical, and therapeutic challenges;B Udd;Lancet Neurol,2012

3. Repeat-associated non-ATG (RAN) translation in neurological disease;JD Cleary;Hum Mol Genet,2013

4. Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA;TM Wheeler;Science,2009

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potential of oleic acid supplementation in myotonic dystrophy muscle cell models;Biological Research;2024-05-17

2. Recent Progress and Challenges in the Development of Antisense Therapies for Myotonic Dystrophy Type 1;International Journal of Molecular Sciences;2022-11-01

3. Molecular Therapies for Myotonic Dystrophy Type 1: From Small Drugs to Gene Editing;International Journal of Molecular Sciences;2022-04-21

4. Proof of concept of peptide-linked blockmiR-induced MBNL functional rescue in myotonic dystrophy type 1 mouse model;Molecular Therapy - Nucleic Acids;2022-03

5. Cellular Senescence and Aging in Myotonic Dystrophy;International Journal of Molecular Sciences;2022-02-20